UnitedHealth Group (NYSE: UNH), a number one supplier of medical health insurance and healthcare companies, is anticipated to report fourth-quarter earnings subsequent week. The corporate, a market chief within the nation’s colossal healthcare business, delivered a combined efficiency in 2024 amid headwinds like Medicare charge cuts and rising healthcare prices.
The diversified firm has a powerful observe document of dividend funds, virtually doubling the payout prior to now 5 years. That makes it a pretty funding for earnings buyers. Growing profitability and the administration’s optimistic earnings outlook for the 12 months counsel extra dividend hikes. In 2024, UnitedHealth’s inventory grew steadily and set a brand new document, however suffered a pointy fall and reversed most of these features after the tragic assassination of UnitedHealthcare CEO Brian Thompson in early December. Nevertheless, it’s regaining momentum forward of the earnings.
The corporate will publish its fourth-quarter report on Thursday, January 16, at 5:55 am ET. On common, analysts following UnitedHealth predict adjusted revenue of $6.75 per share for the quarter, in comparison with $6.16 per share in This fall 2023. It’s estimated that whole revenues rose 7.8% year-over-year to $101.78 billion within the ultimate three months of fiscal 2024.
Outlook
Within the September quarter report, the administration stated it expects full-year 2024 earnings to be within the vary of $27.50 per share to 27.75 per share, adjusted for one-off gadgets. On the midpoint, the estimate is larger than the revenue the corporate earned in 2023. Unadjusted revenue is anticipated to be between $15.50 per share and 15.75 per share in FY24.
The enterprise has confronted stress from rising healthcare prices, resulting in elevated declare payouts to clients. The brand new regulation permitting the federal government to straight negotiate drug costs with pharmaceutical firms to cut back drug prices for Medicare beneficiaries is including to the pressure on revenues. Whereas UnitedHealth has robust fundamentals and a wholesome stability sheet, it has a comparatively excessive debt. The excellent news is that the corporate’s money flows have been fairly robust.
From UnitedHealth’s Q3 2024 earnings name:
“For over 20 years, there was a bipartisan consensus amongst healthcare consultants and policymakers that value-based care that’s built-in, patient-centered, and outcome-focused care is superior to the usually fragmented and unnecessarily costly fee-for-service system. Throughout 4 presidential administrations, CMS has referred to as for private-public innovation within the improvement of value-based care fashions in Medicare and Medicaid. It offers higher outcomes for sufferers. It saves cash for the shoppers and taxpayers who fund care.“
Key Metrics
Within the third quarter, revenues grew by 9% to about $100 billion and barely exceeded Wall Road’s expectations, persevering with the current development. All 4 enterprise segments delivered development, translating right into a 9% rise in adjusted earnings to $7.15 per share. Apparently, quarterly earnings beat estimates constantly for over a decade. Web earnings attributable to the corporate, together with particular gadgets, elevated to $6 billion or $6.51 per share in Q3 from $5.8 billion or $6.24 per share within the prior-year quarter.
After dropping about 7% prior to now 30 days, UnitedHealth’s inventory traded larger on Wednesday afternoon. The inventory’s present value virtually matches its worth round three years in the past.
